Vital Therapies, Inc. (VTL) was a big mover last session, as its shares rose almost 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the company since Sep 30, as the stock is now down over 20%.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Vital Therapies currently has a Zacks Rank #4 (Sell) while its Earnings ESP is negative.

Other better-ranked biomedical stocks include Halozyme Therapeutics, Inc. (HALO), Merrimack Pharmaceuticals, Inc. (MACK) and Illumina Inc. (ILMN). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



VITAL THERAPIES INC (VTL): Free Stock Analysis Report

HALOZYME THERAPEUTICS INC (HALO): Free Stock Analysis Report

MERRIMACK PHARMACEUTICALS INC (MACK): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report


Zacks Investment Research